Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Œsophage » Néoplasie

09. Septembre 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Troubles de la motilité

Écriture:

Page 1 de 1983


	Articles 1 - 20 / 39643

	Effectiveness of Risk-based Sequential Screening for Esophageal and Gastric Cancer (ERSS-EGC): A study protocol for a randomized controlled trial. Chin J Cancer Res Liu M, Tian H, Huo Y, Ma J, Guo C, Xue W, Wu Q, Chen K, Li S, Li W, Liu Z, Yang W, Chen F, Sun J, Duan J, Zhang M, Pan Y, Liu Y, Chen H, Hu Z, Liu F, Wang Y, He Z, Ke Y. PMID: 42713235 [PubMed]
	Perioperative immunochemotherapy for resectable gastric or gastroesophageal junction cancer: a meta-analysis of efficacy and safety from randomized trials. Front Immunol Xu J, Li XM, Yang C, Zhang R, Lyu HL, Wang L, Xie J. PMID: 42712475 [PubMed - indexed for MEDLINE]
	Radiation dose and pathological complete response rate of neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma: aÂ model-based dose-response meta-analysis. Strahlenther Onkol Jiang Y, Su T, Li Q, Feng X, Chen M, Bao W, Ye Z, Dang X, Ji Y, Yang Y. PMID: 42711378 [PubMed - as supplied by publisher]
	Metabolic predictors of response to immunotherapy in locally advanced or metastatic esophageal cancer: unveiling the obesity paradox. Sci Rep Tan J, Zhang H, Pan Z, Chen Y, Cui X, Wang X, Zhu G. PMID: 42711346 [PubMed - indexed for MEDLINE]
	Early recurrence patterns after neoadjuvant chemoradiotherapy and chemoimmunotherapy in esophageal squamous cell carcinoma: A multicenter study. Eur J Cardiothorac Surg Sun C, Chen C, Sun H, Liu H, Chen Q, Wang Z, Chen J, Cho WC, Li Z, Liu Z, Ma D, Ye M, Wang C, Wang Q, Leng X, Han Y, Wang Q, Lv J, Chen H, Zhao J, Yan X, Lv H, Tian Z, Wang C, Xu L, Jiang Y, Zhang Z, Zhong Q, Lin J, Mei X, Li X, Qian D, Zhu C, Guo X, Shen J. PMID: 42711264 [PubMed - as supplied by publisher]
	Camrelizumab plus nimotuzumab as second-line therapy for advanced esophageal squamous cell carcinoma: a multicenter phase II study. J Immunother Cancer Xia J, Meng X, Jiang G, Hong Y, Ji Y, Wang C, Yang X, Meng Y, Zhang W, Luo Z, Cui D, Wang J, Shan Z, Guan L, Lu Y, Yang X, Ren C, Meng X, Wang H, Shen L, Zhang Y, Kou Z, Lu T, Fan Q, Quante M, Zhao T, Li S, Wang F. PMID: 42711069 [PubMed - indexed for MEDLINE]
	First-line systemic therapy for advanced or metastatic esophageal squamous cell carcinoma: clinical implications for treatment selection after KEYNOTE-590, CheckMate 648, and RATIONALE-306. Clin J Gastroenterol Sagawa T, Nagashima H, Fujikawa K. PMID: 42709389 [PubMed - as supplied by publisher]
	Development of a biomarker-guided chemotherapy response model using combined CEA and CA19-9 profiles in esophageal cancer: A real-world pharmacotherapeutic study. Pak J Pharm Sci Can O, Sakin A. PMID: 42708782 [PubMed - indexed for MEDLINE]
	Prognostic nutritional index in evaluating the prognosis of ICIs in patients with advanced esophageal squamous carcinoma. Front Oncol Shi Q, Li M, Wang D, Yang J, Gao J. PMID: 42707258 [PubMed]
	[Adenocarcinomas of the Gastroesophageal Junction and Stomach: Current Management]. Dtsch Med Wochenschr Huber Y, Möhler M. PMID: 42705239 [PubMed - indexed for MEDLINE]
	Long-term trajectories of health-related quality of life after curative surgery in early-stage esophageal cancer: A prospective cohort study in Korea. Eur J Surg Oncol You S, Lee G, Shim YM, Park SY, Cho JH, Choi YS, Lee J, Jeon YJ, Kang D, Batirel HF, Kim HK, Cho J. PMID: 42705092 [PubMed - as supplied by publisher]
	(18)F-FDG PET/CT-based recurrence patterns and survival outcomes in esophageal carcinoma: a single center experience. Radiol Oncol Kotur M, Odalovic S, Petrovic J, Pantic N, Milojevic IG, Saranovic DS, Sabljak P, Artiko V. PMID: 42704040 [PubMed - indexed for MEDLINE]
	Prognostic significance of DNA damage response-related markers in esophageal squamous cell carcinoma using machine learning approaches. J Gastrointest Oncol Huang C, Zhang YJ, Zhang F, Gai CY, Li ZH, Lv HL, Wen SW, Tian ZQ. PMID: 42703410 [PubMed]
	Nodal status and advanced clinical stage as determinants of response and survival after induction chemoradiotherapy in esophageal and gastroesophageal junction cancer: a single-centre retrospective cohort study. J Gastrointest Oncol Schaefer S, Kanjeekal S, Elfiki T, Mathews J, Ghafoor A, Nasser A. PMID: 42703407 [PubMed]
	The association between coffee consumption and esophageal cancer risk: a systematic review and meta-analysis of current observational evidence. J Gastrointest Oncol Zhao Y, Cai Z, Zhang J. PMID: 42703284 [PubMed]
	First-Line PD-1 Inhibitor-Based Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Revised Systematic Review and Meta-Analysis of Phase III Trials. Cancer Rep (Hoboken) Rothweiler V, Roderburg C, Koeksal M, Jensen BEO, Feldt T, Gencer I, Fischer JC, Budach W, Knoefel WT, Lu G, Bölke E. PMID: 42702772 [PubMed - indexed for MEDLINE]
	Risks of adverse respiratory outcomes in adults with cancer over the course of survivorship compared with cancer-free individuals: a matched cohort study using linked English electronic health records. EClinicalMedicine Andresen K, Carreira H, Forbes H, Bowen L, Quint JK, Williamson E, Bhaskaran K. PMID: 42701415 [PubMed]
	Antibody-Drug Conjugates in the Treatment of Esophageal Cancer. Curr Treat Options Oncol Wu D, Chen W, Zhao Q, Zhu W, Xu J. PMID: 42700288 [PubMed - indexed for MEDLINE]
	Efficacy and Safety of DVDMS-Photodynamic Therapy for Dysphagia in Advanced Esophageal Cancer: A Phase II Clinical Trial. Cancer Sci Zhou J, Gao S, Yuan J, Chen H, Shu Y, Fan H, Cao Y, Shan T, Dong C, Zhang H, Song Q, Xin B, Zhang H, Lu Z, Shen L. PMID: 42700165 [PubMed - as supplied by publisher]
	QResearch primary care records linked to national hospital and cancer registry data: a validation study. ESMO Real World Data Digit Oncol Kulkarni S, Perletta V, Wang Z, Tomlinson JW, Hippisley-Cox J, Collins GS, Clift AK, Dodwell D, Lord SR. PMID: 42699058 [PubMed]

Articles 1 - 20 / 39643

Page 1 de 1983



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité